Skip to content

ESKARGOT Study

Exploratory Study on the Effect of Traditional Japanese Medicine (Kampo Medicine) Administration with Goshajinkigan for Tinnitus: A Single-Arm, Pre-and Post-Comparative Study - ESKARGOT Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs051250166
Enrollment
70
Registered
2025-12-15
Start date
2026-04-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic tinnitus

Interventions

Oral administration of Tsumura Goshajinkigan (Traditional Japanese medicine: Kampo medicine) extract granule 7.5g daily in 3 divided doses (2.5g per packet 3 times a day) before each meal for 12 weeks

Sponsors

Okayasu Tadao
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with chronic tinnitus with a duration of illness of more than 3 months (diagnosis is made by interview. Unilateral or bilateral) 2) Patients aged 50 years and older 3) Performance Status (ECOG) of 0 or 1 4) Patients who have given their written consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Patients being treated with traditional Japanese medicines (Kanpo medicines) 2) Patients undergoing tinnitus acoustic therapy 3) Patients with tinnitus associated with hearing loss diseases such as sudden deafness, acute low-pitched sensorineural hearing loss, and Meniere's disease, and in the acute phase within 3 months of onset 4) Patients who have participated in other clinical trials within 3 months prior to the start of study drug administration 5) Patients with dementia (diagnosed with dementia or scoring 20 or less on the Hasegawa scale) 6) Patients with psychiatric diseases who require medication 7) Patients with liver diseases who require medication 8) Patients with interstitial pneumonia 9) Patients who are allergic to therapeutic agents 10) Pregnant patients or patients with possible pregnancy 11) Patients who are deemed inappropriate as research subjects by the principal investigator or subinvestigator.

Design outcomes

Primary

MeasureTime frame
Comparative change in tinnitus distress intensity score (THI) between enrollment and 12 weeks

Secondary

MeasureTime frame
Change from enrollment to 12 weeks for the following items -Pain severity of tinnitus (VAS) -Magnitude of tinnitus (VAS) -Duration of tinnitus (VAS) -Tinnitus (Loudness level) -Assessment of depression and anxiety (HADS) -Availability of indications for Goshajinkigan (Traditional Japanese medicine, Kampo medicine) Secular change in the following items -Tinnitus distress score (THI) -Pain severity of tinnitus (VAS) -Magnitude of tinnitus (VAS) -Duration of tinnitus (VAS) -Adverse event

Contacts

Public ContactTadao Okayasu

Nara Medical University Hospital

tokayasu@naramed-u.ac.jp+81-744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026